It is well accepted that glutamate stimulates in vivo and in vitro gonadotropin-releasing hormone (GnRH) and/or luteinizing hormone (LH) release. The present study aimed to determine whether the arcuate nucleus (ARC) has a role in exerting the modulating effect of estrogen on GnRH response to glutamate. The effects of estrogen on glutamate-induced in vitro GnRH release from either the ARC-median eminence (ME) or ME fragment were examined in female rats. Both high and low doses of estradiol-17β treatment in ovariectomized OVX animals enhanced glutamate-induced GnRH release from the ARC-ME fragment but not from the ME fragment. This suggests that the ARC mediates the facilitating effect of estrogen on glutamate-induced GnRH release from the ARC-ME. The facilitating effect of estrogen was also observed on GnRH release from the ARC-ME treated with selective excitatory amino acid agonists, i.e., N-methyl-D-aspartate (NMDA), kainate, and α-amino-3hydroxy-5-methyl-4-isoxazole propionic acid. These results suggest that the ARC plays an important role in facilitating estrogen actions on GnRH response to glutamate via both NMDA and non-NMDA receptors. The estrogen-induced enhancement of GnRH secretory response to glutamate in the ARC-ME region could partly contribute to the induction of preovulatory GnRH/LH surge.
lutamate, an endogenous excitatory amino acid (EAA), is one of the major neurotransmitters in the regulation of gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) secretion [1, 2] . EAAs are considered to mediate the positive feedback effect of estrogen on LH secretion, because steroid-induced LH surges in female rats are blocked by EAA antagonists [3] . In addition, endogenous EAA release in the preoptic area (POA) [4] and mediobasal hypothalamus (MBH) [5] increases during steroid-induced LH surges. Estrogen may exert the feedback effect on LH secretion by modulating GnRH response to glutamate, because glutamate agonists stimulate in vivo LH release in the presence of estrogen but they do not stimulate or even inhibit LH secretion in the absence of estrogen [6] [7] [8] [9] [10] .
Glutamate stimulates GnRH secretion by acting at the POA [1, 4] , where most GnRH cell bodies are located, and at the arcuate nucleus-median eminence (ARC-ME) region [11] [12] [13] , where the majority of GnRH neurons terminate. In the latter region, both ME and ARC seem to be the action sites of glutamate in the enhancement of GnRH release. In the ME, glutamate stimulates GnRH release by directly acting on GnRH neuronal terminals via N-methyl-D-aspartate (NMDA) and non-NMDA receptors [11, 14] . The ARC contains both EAA immunoreactivities in presynaptic axons [15] and EAA receptors [16, 17] . The ARC also contains many estrogen receptors [18, 19] and some of them are co-localized with glutamate receptors [20] . Furthermore, glutamate induced GnRH release from an ARC-ME fragment in the presence of estrogen [13] . We, therefore, hypothesized that estrogen alters GnRH response to glutamate in the ME by modulating interneuronal activities in the ARC.
To determine whether the ARC mediates the facilitating effect of estrogen on GnRH response to glutamate, the present study investigated the effect of estrogen on glutamate-induced in vitro GnRH release from the ME with or without an ARC region. In addition, the EAA receptor subtype(s) involved in the modulation of GnRH response to glutamate by estrogen were determined.
Materials and Methods

Animals
Adult female Wistar-Imamichi strain rats weighing 220-300 g were used. Animals were individually housed in a controlled environment (14 h light: 10 h dark, lights on at 0500 h, temperature at 22 ± 2 C) and were provided food (Labo-MR-stock, Nihon Nosan Kogyo Co., Yokohama, Japan) and water ad libitum.
Animals having shown at least two consecutive 4 -d a y e s t r o u s c y c l e s w e r e b i l a t e r a l l y ovariectomized (OVX) two weeks prior to in vitro experiments, and were divided into 3 groups. Some of the OVX animals were immediately implanted subcutaneously with Silastic tubing (id, 1.5 mm; od, 3.0 mm; length, 25 mm; Dow Corning, Midland, MI, USA) containing estradiol-17β (E2, Sigma Chemical Co., St. Louis, MO, USA) dissolved in peanut oil at 20 µg /ml to serve as the OVX+ low E 2 group. This E 2 treatment has been confirmed to give a physiological level of plasma E 2 (27.9 ± 0.6 pg/ml) in OVX rats and to have a negative but not a positive feedback effect on LH secretion [21] . Some of the other OVX animals were implanted with Silastic tubing (id, 1.0 mm; od, 1.5 mm; length, 25 mm; Dow Corning) containing crystalline E 2 two days before the in vitro experiment to serve as the OVX+high E2 group. This E2 treatment has been confirmed to give a plasma level of E2 507.0 ± 50.6 pg/ml in OVX rats and to induce daily LH surges [22] . The remaining animals were kept without estrogen treatment, thus serving as the OVX group.
Experimental protocol
After decapitating the animals between 13:00 and 13:30 h, the brain was quickly removed and placed dorsal face down in medium, Yamamoto's solution (in mM: NaCl, 145; KCl, 5; MgCl2, 2; NaHCO3, 5; CaCl2, 2, pH 7.3-7.4) containing 10 mM HEPES, 5.6 mM D-glucose, 0.05% bovine serum albumin and 10 mM bacitracin. ARC-ME or ME tissue fragments were dissected from the brain with a micro-knife. The rest of the brain was fixed with 10% formalin, and 50-µm coronal sections were made with a cryostat. Sections were stained with buffered thionin and observed under a microscope to verify whether the whole ARC-ME region or ME had been correctly dissected. The results obtained from tissues containing only the whole ARC-ME region or ME were included.
ARC-ME or ME fragments were incubated at 37 C in 500 µl of the medium gassed with 95% O2/5% CO2 in a water bath with constant shaking. After 30 min preincubation, tissues were incubated in the medium containing each drug for 30 min. The medium was collected and stored at -20 C until assayed for GnRH.
Drugs
Glutamate, NMDA, kainate and α-amino-3hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) were purchased from Tocris Neuramin Ltd., Bristol, England. These drugs were used immediately after dissolving in the medium at concentrations of 5, 10 and 20 mM. The doses were chosen according to the results of previous studies [11, 13, 23] .
Assay
GnRH contents in the medium were measured by a double-antibody radioimmunoassay using a rabbit anti-GnRH serum (RIX-419) provided by Dr. Hasegawa of Kitazato University [24] and [ 125 I]-GnRH purchased from Amersham Co. (Tokyo, Japan). Authentic GnRH was obtained from Sigma and used as a standard. The least detectable GnRH level was 0.39 pg/tube. The intra-and inter-assay coefficients of variation were 2.7 and 5.3% at levels of 6.2 and 12.9 pg/tube, respectively.
Data analysis
Statistical differences between OVX and E2treated groups were determined by one-way ANOVA followed by Fisher's protected least significant difference post-hoc test.
Results
Dissections of ARC-ME or ME tissue fragments
The part of the brain remaining after dissection of the ME (Fig. 1, upper) and ARC-ME (Fig. 1, lower) region shows that only the ME and ARC-MEwere dissected out with the other parts of the brain left intact.
Effect of high and low doses of E2 on glutamateinduced GnRH release from ARC-ME or ME fragments
Glutamate increased in vitro GnRH release from ARC-ME or ME fragments in OVX, OVX+low E2 and OVX+high E2 groups in a dose-dependent manner (Fig. 2 ). GnRH release from ARC-ME induced by 10 mM glutamate in the low or high E2treated OVX group was significantly (P<0.05) higher than in the corresponding OVX group. GnRH release from ARC-ME induced by 20 mM glutamate was significantly (P<0.01) increased by h i g h E 2 t r e a t m e n t c o m p a r e d w i t h t h e corresponding OVX and OVX+low E 2 groups. On the other hand, no significant difference was found in GnRH release from ME fragments in low or high E2-treated groups compared with corresponding OVX controls.
Effect of high and low doses of E 2 on specific EAA agonist-induced GnRH release from ARC-ME fragments
GnRH release from ARC-ME fragments induced by 5 mM NMDA in the high E2-treated group was s i g n i f i c a n t l y ( P < 0 . 0 5 ) h i g h e r t h a n i n t h e corresponding OVX and low E 2 -treated groups (Fig. 3 ). 10 mM NMDA in low E 2 and high E 2treated groups significantly (P<0.05) increased GnRH release from the ARC-ME compared with the corresponding OVX group. GnRH release induced by 10 mM kainate in the low E2-treated group was significantly (P<0.05) higher than in the corresponding OVX or high E 2 -treated groups. GnRH release from ARC-ME fragment induced by 20 mM kainate in the high E2-treated group was s i g n i f i c a n t l y ( P < 0 . 0 5 ) h i g h e r t h a n i n t h e corresponding OVX or low E2-treated groups. GnRH release from ARC-ME induced by 10 mM AMPA in both low and high E 2 -treated groups was s i g n i f i c a n t l y ( P < 0 . 0 5 ) h i g h e r t h a n i n t h e corresponding OVX group.
Discussion
The present study demonstrated that estrogen enhances the stimulatory effect of glutamate on in vitro GnRH release from the ARC-ME region, but not from the ME alone. This result suggests that the ARC has a critical role in facilitating the effect of estrogen on glutamate-induced GnRH release from the nerve terminal of GnRH neurons. The ARC contains a considerable number of estrogen receptors [18, 19] . Thus, estrogen may directly act on the ARC and then enhances glutamate-induced GnRH release. The present study suggests that glutamateinduced GnRH release in the presence of estrogen is mediated by both NMDA and non-NMDA receptors, because estrogen enhanced the GnRH release induced by NMDA, kainate and AMPA. Previous studies demonstrated that the ARC contains all of these receptor subtypes [1, 17, 25, 26] . Estrogen receptors are expressed at AMPA receptor-containing neurons in the ARC, and estrogen stimulates AMPA receptor expression in the ARC [1, 20] , suggesting that estrogen may directly modulate the response of AMPA receptor-containing neurons in the ARC. Kainate receptors have been suggested to be involved in steroidinduced GnRH/LH surge [27] . Functions of the AMPA receptor are enhanced by the activation of NMDA receptors [28, 29] . Therefore, co-activation of NMDA and non-NMDA receptors at the ARC may be required to exert the complete effect of estrogen on GnRH release.
Excitatory amino acids mediate steroid-induced gonadotropin surge [3] , and the estrogen positive feedback mechanism through the glutamatergic system could be explained as follows. Ovarian steroids seem to enhance both glutamate release at GnRH nerve terminals and GnRH secretory response to glutamate. This is because endogenous EAA release in the MBH increases during steroidinduced LH surges in the rat [5] , and estrogen stimulates glutamate-induced GnRH as shown in the present study. Interestingly, even the low doses of estrogen, which has a negative feedback effect on LH release in vivo, enhanced glutamate-induced GnRH release from the ARC-ME in the present study. This result suggests that estrogen at any dose enhances GnRH release induced by glutamate when the ARC-ME region is isolated from other brain regions.
Considering the presence of a numerous number of estrogen receptors in the ARC [18, 19] , it is possible that the ARC is one of the action sites of estrogen involved in the induction of GnRH/LH surge via the glutamatergic system. The POA is well accepted as a major positive feedback action site of estrogen in the rat [30] . On the other hand, the MBH is reported to be a positive feedback action site in the ewe [31] , suggesting that brain regions other than the POA could be positive feedback action sites of estrogen. The involvement of the ARC in the induction of GnRH surge has also been demonstrated in the rat by a morphological study in which the number of axosomatic synapses in the ARC fell according to the preovulatory rise in estrogen, and estrogen immuno-neutralization abolished this synaptic retraction in the ARC [32] . These results and the present study raises the possibility that the ARC could be one of the positive feedback action sites of estrogen to induce GnRH/LH surges.
In conclusion, the present study suggests that the ARC mediates the facilitating effect of estrogen on glutamate-induced in vitro GnRH release through NMDA, kainate and AMPA receptors. The estrogen enhancement of GnRH secretory response to glutamate in the ARC-ME region may partly contribute to the preovulatory induction of GnRH/ LH surge.
